Abstract |
This is a report of the research presented at the 11th Annual Meeting of the International Pachyonychia Congenita Consortium, held on 6 May 2014 in Albuquerque, NM, U.S.A. This year's meeting was divided into five corners concerning pachyonychia congenita (PC) research: (i) 'PC Pathogenesis Cornered', an overview of recent keratin research, for PC and other skin disorders; (ii) 'From All Corners of …', an outline of other genetic disorders that we can learn from; (iii) 'Fighting For Our Corner', an outline of National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases programmes and U.S. funding opportunities applicable to rare skin disorders; (iv) 'The PC Corner', focusing on recent clinical studies related to PC; and (v) 'Clinical Corners: Turning the Corner?', an update on ongoing PC clinical trials.
|
Authors | E A O'Toole, R L Kaspar, E Sprecher, M E Schwartz, L Rittié |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 171
Issue 5
Pg. 974-7
(Nov 2014)
ISSN: 1365-2133 [Electronic] England |
PMID | 25124823
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2014 British Association of Dermatologists. |
Chemical References |
- Dermatologic Agents
- Capsaicin
- Sirolimus
|
Topics |
- Administration, Cutaneous
- Capsaicin
(administration & dosage)
- Congresses as Topic
- Dermatologic Agents
(administration & dosage)
- Humans
- Mutation
(genetics)
- Off-Label Use
- Pachyonychia Congenita
(diagnosis, drug therapy, etiology)
- Sirolimus
(administration & dosage)
|